苯二氮卓金標(biāo)檢測(cè)卡

廣州健侖生物科技有限公司

廣州健侖生物長(zhǎng)期供應(yīng)各種違禁品檢測(cè)試紙、違禁品檢測(cè)卡、違禁品檢測(cè)試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測(cè)試劑盒、巴比妥檢測(cè)試劑盒等。

主營(yíng)品牌：美國(guó)NovaBios、美國(guó)Cortez、國(guó)產(chǎn)創(chuàng)侖等等。

主要用途：篩查違禁品濫用殘留、麻醉藥殘留、興奮藥物殘留等等。

檢測(cè)范圍：嗎啡、KET、mamp、MDMA、BZO、THC、巴比妥、MTD、BAR、MDMA、AMP、BUP、PCP、TCA、OXY、MET等等。 

以下可以自由COMBO多聯(lián)檢測(cè)卡：

苯二氮卓檢測(cè)試紙

苯二氮卓檢測(cè)試紙

苯二氮卓快速檢測(cè)試紙

苯二氮卓快速檢測(cè)試紙

苯二氮卓金標(biāo)檢測(cè)卡

產(chǎn)品特點(diǎn)：可以根據(jù)需求自主訂制多聯(lián)卡。多聯(lián)卡自由組合，從二聯(lián)到十五聯(lián)都可以訂制。

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

如需訂購(gòu)或者了解請(qǐng)以下或

mob： 楊   ：

更多產(chǎn)品說(shuō)明可通過(guò)下方的進(jìn)行了解

添加掃一掃二維碼：

【公司名稱(chēng)】 廣州健侖生物科技有限公司

【 市場(chǎng)部 】       楊永漢
【】 
【騰訊  】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室

It is estimated that about 2.1 billion people live in malaria-endemic areas, with 100 million clinical cases each year and approximay 1 million to 2 million deaths. At present, there are more than 300 million people living in non-protected areas without any special anti-malaria measures, and most of Africa is a non-protected area. For this reason, at least 1 million children under the age of 14 die of malaria with malnutrition and other health problems each year in Africa alone. Schistosomiasis is endemic in 76 countries and regions, with approximay 200 million schistosomiasis patients and 500-600 million people infected. [9] The mosquito-borne lymphatic filariasis is affected by 250 million people. Among them, Bancroftian filariasis is global. There are about 900 million inhabitants living in the threatened areas in Southeast Asia, Africa, the Americas and the Pacific. Most tropical countries in the island countries are particularly serious. The tick-borne onychomycosis causes skin filariasis and river blindness. It is estimated that there are 17.6 million patients worldwide, which are widely distributed in Africa and Latin America, and that 15% of patients are blind in severe areas. The epidemic of leishmaniasis is mainly distributed in the tropical and subtropical regions, and it is distributed worldwide. There are approximay 400,000 newly infected patients each year. The disease is spreading in East Africa. Trypanosomiasis, of which about 45 million people are threatened by the infection of African trypanosomiasis (sleep disease); the number of Chagas disease (Chagas disease) infected in South America is at least 10 million. In addition, intestinal protozoal and helminthic infections (intestinal protozoal and helminthic infections) are also threatening human health. The important species are global amoebiasis, giardia lamblia, tsutsugamushi disease, whipworm disease, and hooking. Insect disease, tsutsugamushi disease, there are also some local intestinal helminthiasis, such as pig tapeworm, tapeworm and so on. Peters (1989) estimated that the number of locusts, whipworms, hookworms, and roundworms infected worldwide was 1.283 billion, 870 million, 716 million, and 360 million. In Asia, Africa, and Latin America, especially in agricultural areas, sewage irrigation and the use of fresh faeces are conducive to the spread of intestinal parasites; among malnourished residents, intestinal parasites have a more severe impact on their health. In the underdeveloped regions, especially in the rural poor, mixed infections of multiple parasites are common. The incidence of intestinal parasites has been considered as a basic measure of economic and cultural development in a region. Some people claim that parasitic diseases are "village disease" and "poor disease". It is a cause and effect of social economic and cultural backwardness. Therefore, parasitic diseases are one of the important reasons that hinder the development of third world countries. [9] In economically developed countries, parasitic diseases are also an important issue in public health.